HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diode laser photocoagulation posterior to the ridge in severe stage 3+ threshold retinopathy of prematurity.

AbstractPURPOSE:
To evaluate the results of diode laser photocoagulation (DLP) of the retina posterior to the ridge in eyes with severe Zone II, Stage 3+ threshold retinopathy of prematurity (ROP).
METHOD:
DLP was applied posterior to the fibrovascular ridge for advanced Zone II, Stage 3+ threshold ROP patients, either as the primary treatment combined with DLP of the avascular retina (group 1), or as a secondary treatment in eyes that had previously undergone DLP of the avascular retina (group 2). Statistical analysis was performed using SPSS software trail version 16.0. Values are presented as mean ± SD.
RESULTS:
A total of 50 eyes of 29 premature infants were treated (14 [48%] male, 15 [52%] female). The mean gestational age was 29.5 ± 2.2 weeks (range: 26-34 weeks). The mean birth weight was 1259 0.72 ± 409.15 g (range: 500-2050 g). The mean gestational age for DLP of the avascular region anterior to the ridge and DLP posterior to the ridge was 37 ± 3 weeks and 38 ± 3 weeks, respectively. The mean follow-up was 26 ± 5 weeks (18-38 weeks). In 48 eyes, the tractional fibrovascular ridge had regressed. Transient retinal hemorrhage was the most common complication. Three eyes exhibited optic-disc dragging; two eyes progressed to Stage 4a ROP; two eyes presented with macular traction, without any detachment; and one eye developed a vitreous hemorrhage, which resolved spontaneously. There were no statistically significant differences between complicated and uncomplicated eyes regarding gestational age, birth weight and applied laser spot numbers (p > 0.05 for all, Mann-Whitney U test).
CONCLUSION:
DLP, posterior to the ridge as an additive treatment in the management of severe Zone II, Stage 3+ threshold ROP patients, is safe and effective; this approach could be used as either the primary treatment, or as the follow-up to failed laser treatment of the avascular retina to halt the progression of the disease.
AuthorsSema Arvas, Ahmet Murat Sarici, Solmaz Akar
JournalCutaneous and ocular toxicology (Cutan Ocul Toxicol) Vol. 33 Issue 3 Pg. 197-200 (Sep 2014) ISSN: 1556-9535 [Electronic] England
PMID24147941 (Publication Type: Journal Article)
Topics
  • Female
  • Humans
  • Infant, Extremely Premature
  • Infant, Newborn
  • Infant, Premature
  • Laser Coagulation
  • Lasers, Semiconductor
  • Male
  • Retinopathy of Prematurity (surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: